FDA Declines to Approve Regeneron`s Blood Cancer Drug
02 Aug 2025 //
REUTERS
Allogene Reports Patient Death, Discontinues CAR-T Pivotal Trial
02 Aug 2025 //
FIERCE BIOTECH
Spine Bio Pharma Misses Primary Endpoint in Back Pain Phase 3
02 Aug 2025 //
FIERCE BIOTECH
Sanofi pens $395M China pact for Arrowhead Metabolic med
02 Aug 2025 //
PRESS RELEASE
4 DMT Climbs as Gene Therapy Patients Keep Jettisoning Jabs Climb
02 Aug 2025 //
FIERCE BIOTECH
Sun Pharma Q1 Net Profit Down 20%, Revenue Up 9%
01 Aug 2025 //
BUSINESS STD
Poxel Changes Governance Post Reorganization Filing
01 Aug 2025 //
BUSINESSWIRE
Frazier Life Sciences raises $1.3B for early-stage biotech fund
01 Aug 2025 //
FIERCE BIOTECH
Zenara Pharma Gets FDA Nod for First Generic Sertraline
01 Aug 2025 //
PR NEWSWIRE
Drugs In Development

Market Intel
